NCT00355771View on ClinicalTrials.gov

Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Allergic Rhinitis
Interventions
DRUG

Levocetirizine

Intake of 1 tablet of Levocetirizine 5mg OD for 8 weeks

DRUG

Placebo

1 tablet OD in the morning for 8 weeks

Trial Locations (1)

610041

Department of ORL, West China Hospital, Sichuan Hospital, Chengdu

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Institut für Atemwegsforschung GmbH

INDUSTRY